Roemmers S.A.I.C.F.

An EMIS Company Report EMIS is a Euromoney Institutional Investor plc company USD 9.95 Industry: Pharmaceutical and Medicine Manufacturing Available in: English & Spanish Format: PDF Download Buy full report

What’s included?

This report extracts all available information about Roemmers S.A.I.C.F. from EMIS' database of company information. The Table of Contents on the right indicates the categories of information that will be included in your report upon purchase.

Download a sample report

Company Tear Sheet (locked content will be provided in the purchased report)

Contact Information

Fray Justo Sarmiento 2350
Olivos; Buenos Aires; Map
Postal Code: B1636ASX

Tel: +54-11-4346-
Fax: +54-11-4334-



Company Description
Laboratorios Roemmers is an Argentine company. It was founded in 1921 by Don Alberto J. Roemmers who, originally from Lennep, region of Rhineland in Germany, sought new horizons in Argentina. With the contribution of German technology and having laid the foundations of the pharmaceutical industry, its company was a precursor in the southern hemisphere, and today it is among the most developed in the world in this field. Roemmers has originated important trends in Argentina's therapeutics by launching medicines such as Amoxicillin (amoxicillin), Sertal (propyxox), Atlansil (amiodarone), Taural (ranitidine), Acalix (diltiazem), Lotrial (enalapril), Lanzopral (Lansoprazole), Ciriax (ciprofloxacin) and more recently, Losacor (losartan), Endial (glimepiride), Corbis (bisoprolol) and Plenica (Pregabalin). Roemmers sells 57 million units annually in Argentina, to which is added a significant amount of samples with no commercial value destined to medical professionals. The company’s products are used in the treatment of various health conditions, including coronary, digestive, and respiratory systems and and specialties that include cardiology, pediatrics, clinical practice, geriatrics, and surgery. Its products are also used to treat psychiatric and neurological disorders, as well as rheumatologic and infectious diseases. In addition, the company offers IntraMed, a technological platform that provides medical professionals with tools for teaching, conducting research, and staying current in medical and scientific matters. It exports its products to Europe, the Caucasus region, the Middle East, and countries of the former Soviet Union.
NAICS Industry Classification
Main Activities: Pharmaceutical and Medicine Manufacturing
Basic Information
Total Employees:
Incorporation Date:
March 09, 1948
Profile Updated:
October 05, 2017
Key Executives
Vice President
Enterprise ACCESS

If you need regular and ongoing access to company information, you should consider a subscription to the full EMIS service.

EMIS company profiles are part of a larger information service where that combines company, industry and country data and analysis for over 125 emerging markets on a unique information platform.


To view more information, REQUEST A DEMO